Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Makes Agreements for $30.3 million in Private Equity Financing

NEW YORK, Feb. 27 (GenomeWeb News) - Orchid BioSciences announced today that it has entered into agreements to raise about $30.3 million in common stock private equity financing.


According to the agreements, Orchid will sell about 15.8 million shares of common stock at $1.92 per share, with four-year warrants issued for the purchase of an additional 3.2 million shares at $2.64 per share. The deal is expected to close today.


The financing move comes as part of Orchid's ongoing capital restructuring efforts, the company said.


The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.